January 30, 2019
Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
Read More
January 30, 2019
Study Assessing Double-masked Uveitis Treatment
Read More
January 30, 2019
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Read More
January 30, 2019
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Read More
January 30, 2019
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC
Read More
January 30, 2019
Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib
Read More
January 30, 2019
An Extension Treatment Protocol for Subjects Who Have Participated in a Phase 3 Study of Tivozanib Versus Sorafenib in Renal Cell Carcinoma (Protocol AV-951-09-301)
Read More
January 30, 2019
A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma
Read More
January 30, 2019
Study of Efficacy, Safety, and Quality of Life of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Prior Checkpoint Inhibitor Treatment
Read More
January 30, 2019
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
Read More
January 30, 2019
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
Read More
January 30, 2019
A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma
Read More
Load More
X